Literature DB >> 25261576

Statistical review: frequently given comments.

Stian Lydersen.   

Abstract

From 2006 to 2014, I have carried out approximately 200 statistical reviews of manuscripts for ARD. My most frequent review comments concern the following: 1. Report how missing data were handled. 2. Limit the number of covariates in regression analyses. 3. Do not use stepwise selection of covariates. 4. Use analysis of covariance (ANCOVA) to adjust for baseline values in randomised controlled trials. 5. Do not use ANCOVA to adjust for baseline values in observational studies. 6. Dichotomising a continuous variable: a bad idea. 7. Student's t test is better than non-parametric tests. 8. Do not use Yates' continuity correction. 9. Mean (SD) is also relevant for non-normally distributed data. 10. Report estimate, CI and (possibly) p value-in that order of importance. 11. Post hoc power calculations-do not do it. 12. Do not test for baseline imbalances in a randomised controlled trial. 13. Report actual p values with 2 digits, maximum 3 decimals. 14. Format for reporting CIs. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Epidemiology; Outcomes research; Treatment

Mesh:

Year:  2014        PMID: 25261576     DOI: 10.1136/annrheumdis-2014-206186

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.

Authors:  L M Ørnbjerg; M Østergaard; T Jensen; K Hørslev-Petersen; K Stengaard-Pedersen; P Junker; T Ellingsen; P Ahlquist; H Lindegaard; A Linauskas; A Schlemmer; M Y Dam; I Hansen; T Lottenburger; C G Ammitzbøll; A Jørgensen; S B Krintel; J Raun; M L Hetland; Ole Slot; Lars Kjær Nielsen; Henrik Skjødt; Ole Majgaard; Tove Lorenzen; Hans Christian Horn; Marcin Kowalski; Inger Lauge Johansen; Peter Mosborg Pedersen; Natalia Manilo; Henning Bliddal
Journal:  Clin Rheumatol       Date:  2016-12-05       Impact factor: 2.980

2.  Effects of medication-treated diabetes on incidence and progression of knee osteoarthritis: a longitudinal analysis of the Osteoarthritis Initiative data.

Authors:  Ivan V Shirinsky; Valery S Shirinsky
Journal:  Rheumatol Int       Date:  2017-02-28       Impact factor: 2.631

Review 3.  Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis.

Authors:  Markus Bredemeier; Guilherme G Campos; Fernando K de Oliveira
Journal:  Clin Rheumatol       Date:  2015-06-12       Impact factor: 2.980

4.  Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.

Authors:  Minghua Wu; Brian Skaug; Xiongjie Bi; Tingting Mills; Gloria Salazar; Xiaodong Zhou; John Reveille; Sandeep K Agarwal; Michael R Blackburn; Maureen D Mayes; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2019-08-22       Impact factor: 19.103

5.  Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.

Authors:  Shunsuke Mori; Akitomo Okada; Tomohiro Koga; Yukitaka Ueki
Journal:  PLoS One       Date:  2022-06-23       Impact factor: 3.752

6.  Response to "Comment on 'Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: Two-year follow-up data from the Catholic Axial Spondyloarthritis COhort (CASCO)'".

Authors:  Hong Ki Min; Jennifer Lee; Ji Hyeon Ju; Sung-Hwan Park; Seung-Ki Kwok
Journal:  Clin Rheumatol       Date:  2020-01-11       Impact factor: 2.980

7.  Effectiveness of home-based nutritional counselling and support on exclusive breastfeeding in urban poor settings in Nairobi: a cluster randomized controlled trial.

Authors:  Elizabeth W Kimani-Murage; Paula L Griffiths; Frederick Murunga Wekesah; Milka Wanjohi; Nelson Muhia; Peter Muriuki; Thaddaeus Egondi; Catherine Kyobutungi; Alex C Ezeh; Stephen T McGarvey; Rachel N Musoke; Shane A Norris; Nyovani J Madise
Journal:  Global Health       Date:  2017-12-19       Impact factor: 4.185

8.  H1-antihistamines are associated with lower prevalence of radiographic knee osteoarthritis: a cross-sectional analysis of the Osteoarthritis Initiative data.

Authors:  Ivan Shirinsky; Valery Shirinsky
Journal:  Arthritis Res Ther       Date:  2018-06-07       Impact factor: 5.606

9.  Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis.

Authors:  Jos Hendrikx; Marieke J de Jonge; Jaap Fransen; Wietske Kievit; Piet Lcm van Riel
Journal:  RMD Open       Date:  2016-08-18

10.  Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: results from the Nordic cohort study.

Authors:  Veronika Rypdal; Ellen Dalen Arnstad; Kristiina Aalto; Lillemor Berntson; Maria Ekelund; Anders Fasth; Mia Glerup; Troels Herlin; Susan Nielsen; Suvi Peltoniemi; Marek Zak; Marite Rygg; Martin Rypdal; Ellen Nordal
Journal:  Arthritis Res Ther       Date:  2018-05-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.